Employees: 3,548
Size Jiangsu Baichuan High-Tech New Materials (002455.SZ) is a China Materials company (Chemicals: Specialty) with a market value of $604M, the 3226th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥5.67 on 18 Nov 2026.
Performance Over six months the shares fell 43.3%, against -26.2% for the median peer and -20.0% for the China market (cap-weighted) — 7th lowest of 20 in its peer set.
Growth Revenue grew 9.4% over the last twelve months (peer median +13.2%); the operating margin is 1.3% (peer median 9.3%).
Valuation It trades at 1.6× enterprise value to sales against a peer median of 2.0× (8th cheapest of 21).
Capital Return on invested capital runs 0.2 points above its cost of capital (5.2% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥6.46B | CN¥5.76B | CN¥5.55B | CN¥4.11B | CN¥4.12B |
| Revenue growth | — | +4% | +35% | 0% | — |
| Gross profit | CN¥967M | CN¥250M | CN¥537M | CN¥46.7M | CN¥389M |
| EBITDA | n/a | CN¥715M | CN¥752M | -CN¥190M | CN¥499M |
| Net income | -CN¥50.7M | -CN¥108M | CN¥109M | -CN¥466M | CN¥136M |
| Free cash flow | -CN¥33.3M | CN¥119M | -CN¥6.38M | -CN¥1.15B | -CN¥2.16B |
| Capital expenditure | CN¥582M | CN¥607M | CN¥962M | CN¥1.56B | CN¥2.34B |
| Total debt | CN¥7.20B | CN¥7.49B | CN¥7.42B | CN¥6.35B | CN¥5.27B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 002455.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -11.5% | -9.5% | 9th lowest of 21 |
| 6-month return | -43.3% | -26.2% | 7th lowest of 20 |
| Distance from 52-week high | -66.9% | -51.1% | 2nd lowest of 21 |
| Revenue growth (TTM) | +9.4% | +13.2% | 7th lowest of 21 |
| Operating margin | 1.3% | 9.3% | 6th lowest of 20 |
| EV / Sales | 1.6× | 2.0× | 8th cheapest of 21 |
| ROIC minus cost of capital | +0.2 pp | -2.1 pp | 8th highest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Jiangsu Baichuan High-Tech New Materials 002455.SZ | China | $604M | -43% | +9% | 1% | 1.6× | n/a | n/a |
| Hangzhou Gaoxin Materials Technology 300478.SZ | China | $600M | -21% | -21% | -9% | 12.0× | 29.9% | -0.9% |
| LOTTE Fine Chem 004000.KS | South Korea | $610M | -45% | +18% | 7% | 0.2× | -20.1% | +6.8% |
| Pan Asian Microvent Tech (Jiangsu) 688386.SS | China | $598M | -50% | +12% | 15% | 5.9× | n/a | n/a |
| Dainichiseika Color & Chemicals Mfg.Co 4116.T | Japan | $610M | +23% | +5% | 8% | 0.7× | 1.8% | -2.1% |
| IOL Chemicals & Pharmaceuticals IOLCP.NS | India | $596M | +72% | +27% | 10% | 2.0× | 27.1% | +3.5% |
| Hangzhou Grascent 301688.SZ | China | $613M | n/a | +12% | n/a | 3.6× | 42.9% | n/a |
| Jiangsu Lopal Tech 2465.HK | Hong Kong | $590M | -61% | +107% | 7% | 0.9× | n/a | n/a |
| Cytech 301557.SZ | China | $619M | -1% | +13% | 7% | 3.6× | n/a | n/a |
| Formosan Union Chemical 1709.TW | Taiwan | $619M | +159% | +14% | 41% | 2.0× | -17.9% | +1.2% |
| Cybrid Technologies 603212.SS | China | $588M | -40% | -9% | -7% | 1.8× | n/a | n/a |
| Renxin New Material 301395.SZ | China | $587M | +13% | +1% | -6% | 1.8× | n/a | n/a |
| Anhui Estone Materials Technology 688733.SS | China | $622M | -43% | +52% | -2% | 5.9× | n/a | n/a |
| Zhejiang Jiaao Enprotech Stock 603822.SS | China | $585M | -27% | +101% | 19% | 1.5× | -9.8% | +31.6% |
| MEC 4971.T | Japan | $582M | -52% | +31% | 32% | 3.2× | 16.1% | +11.9% |
| Allied Supreme 4770.TW | Taiwan | $628M | +22% | -5% | 21% | 3.4× | 1.3% | +12.4% |
| Miracll Chemicals 300848.SZ | China | $578M | -46% | +23% | 1% | 2.6× | n/a | n/a |
| Ishihara Sangyo Kaisha 4028.T | Japan | $631M | -7% | +3% | 10% | 0.8× | 2.1% | +8.8% |
| Anshan Hifichem 300758.SZ | China | $631M | -26% | +11% | 9% | 3.1× | 16.0% | +8.2% |
| Hubei Hongyuan Pharmaceutical Technology 301246.SZ | China | $576M | -57% | +45% | 12% | 1.3× | n/a | n/a |
| DKS 4461.T | Japan | $573M | +3% | +31% | 15% | 1.0× | 7.2% | +7.0% |